Treatment Route Glucose levels at varying times in mmole/dL
0hr 1hr 2hr 3hr 4hr 6hr 24hr
Control Oral 5.30 ± 0.28 5.04 ± 0.17 5.02 ± 0.13 5.12 ± 0.23 5.08 ± 0.08 5.18 ± 0.25 4.96 ± 0.21
  IP 5.12 ± 0.18 5.28 ± 0.22 5.28 ± 0.13 5.12 ± 0.22 5.18 ± 0.08 5.22 ± 0.18 5.22 ± 0.29
Diabetic control Oral 24.42 ± 3.18A 25.48 ± 2.79B 26.12 ± 2.35B 26.84 ± 1.92B 27.58 ± 1.45B 28.88 ± 1.11Ba 30.08 ± 1.49Cb
  IP 19.84 ± 1.26A 21.48 ± 1.41B 23.08 ± 1.50Ba 24.24 ± 1.71Ba 25.20 ± 1.36Ab 25.74 ± 1.60Ab 28.04 ± 1.47Cc
Diabetic/Glib Oral 23.80 ± 2.72Ac 20.82 ± 2.43Ab 17.62 ± 3.15Ab 12.62 ± 3.68Aa 8.68 ± 2.00 5.74 ± 1.06 6.82 ± 1.01
Diabetic/Insulin IP 20.88 ± 2.69Bb 7.30 ± 0.54a 6.32 ± 0.44 6.08 ± 0.41 5.46 ± 0.47 4.68 ± 0.38 6.98 ± 0.94a
Extract dose (mg/kg body weight)
50 Oral 25.88  ± 1.12Ac 15.86 ± 2.50Ab 11.78 ± 5.33a 8.02 ± 3.14 5.18 ± 1.62 4.68 ± 1.33 6.66 ± 1.09
IP 15.42  ± 3.05Aa 7.78 ± 1.64 8.22 ± 2.07 6.00 ± 0.98 4.96 ± 1.47 6.02 ± 1.57 8.38 ± 1.54
100 Oral 22.60 ± 4.50Ac 16.76 ± 0.69Ab 14.10 ± 2.06Ab 9.42 ± 0.89a 5.58 ± 0.94 5.10 ± 1.18 7.58 ± 0.59
IP 16.66 ± 3.54Aa 9.68 ± 4.66 8.58 ± 3.43 7.42 ± 2.73 6.06 ± 1.57 7.72 ± 3.06 10.46 ± 2.53B
200 Oral 24.14 ± 4.12Aa 17.18 ± 4.68A 12.60 ± 5.07A 11.48 ± 4.71A 11.36 ± 4.72A 8.90 ± 2.17A 12.00 ± 3.32B
IP 18.20 ± 1.27Ac 13.42 ± 5.10Ab 12.40 ± 4.43Aa 8.78 ± 2.96A 5.68 ± 0.71 7.12 ± 1.51 9.44 ± 2.44A
300 Oral 20.88 ± 3.40Ac 17.30 ± 1.58Ab 14.02 ± 3.41Aa 10.30 ± 3.87 8.10 ± 1.55 7.46 ± 2.86 11.32 ± 4.49A
IP 15.62 ± 3.87Aa 7.76 ± 2.42 7.10 ± 1.88 6.30 ± 1.19 5.50 ± 0.50 5.92 ± 0.71 7.48 ± 1.58
Values are expressed as Means ± SD for five animals per group. Means within respective columns followed by similar upper case letters are not significantly different at p ≤ 0.05 by ANOVA and post ANOVA; means within respective rows followed by similar lower case letters are not significantly different at p ≤ 0.05 by ANOVA and post ANOVA.
Table 1: Effect of oral and intraperitoneal administration of aqueous stem bark extracts Acacia nilotica on blood glucose levels in alloxan induced diabetic mice.